Advances in targeted therapies for Parkinson's disease

Advances in targeted therapies for Parkinson's disease

Parkinson's disease (PD) is the second most common neurodegenerative disease. Although dopamine replacement therapy is the golden standard of PD treatment, there are limitations due to drug⁃related motor complications and loss of long⁃term efficacy. In the recent two decades, rapid advances in...

Full description

Bibliographic Details
Main Authors: Zheng JIANG, Ru⁃wei OU, Hui⁃fang SHANG, Wei SONG
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2019-11-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
parkinson disease
drug therapy
genes
mutation
review
Online Access:http://www.cjcnn.org/index.php/cjcnn/article/view/2055

Internet

http://www.cjcnn.org/index.php/cjcnn/article/view/2055

Similar Items